Padcev, an antibody-drug conjugate which Pfizer acquired via its $43 billion Seagen deal, could help people who don’t qualify ...

Phase 1b/2a immune thrombocytopenia (ITP) trial FPI achieved, enrollment ongoing. Climb Bio is enrolling an open-label, dose-escalation Phase 1b/2a clinical trial of budoprutug in patients with ITP to ...

Ford Is Taking on Expensive EVs and the Toyota RAV4 with Its New 'Model T'—a $30K Mid-Size EV Truck ‘What gives you the right ...

Bristol-Myers Squibb recently reported a strong earnings quarter. **The company raised its full-year revenue guidance by $700 million**. This update reflects robust sales growth from key therapies and ...

Repay said it is appointing Robert Houser, an executive at business processes company Conduent, as its new chief financial officer. Houser is the current group financial chief of the public sector for ...

Some oncologists and researchers have raised concerns about delays in the completion of confirmatory trials, but FDA now has new tools to push them ahead.

Patients with psoriasis have significantly more difficulty sleeping, particularly in new environments, than matched ...

Before the Kansas City Chiefs became perennial Super Bowl contenders, Andy Reid led a textbook organizational turnaround.

New York hospitals that get discounted drugs through a controversial federal program are gearing up for a new pilot that they ...

A new research paper was published in Volume 16 of Oncotarget on July 25, 2025, titled “Dissecting the functional differences and clinical features of R-spondin family members in metastatic prostate ...

Bristol-Myers Squibb Company (NYSE: BMY) is one of the stocks Jim Cramer recently shed light on. When a caller noted that the ...

The report, from 340B Health, claims that changes proposed by major drugmakers to replace upfront discounts with post-sale rebates for outpatient drugs would hit safety-net hospitals with significant ...